Two lines of Lewis lung carcinoma with a different potential to metastasize spontaneously to the lungs have been examined for their cytological and histological characteristics. Metastatic potential appears to be related with parenchymal organization of the primary tumours, since large haemorrhagic areas containing detached tumour cells and the absence of endothelialized capillaries are observed only in the line with high metastatic potential. At the same time, the cytological characteristics of the cells of the two tumour lines are similar, and do not seem to be related with metastatic potential. After treatment with the selective antimetastatic drugs ICRF-159 and DM-COOK, and with DTIC, the histological appearance of the line with high metastatic potential becomes similar to that of the line with low metastatic potential. These data seem to indicate that the early phases of tumour spread occurring in the primary tumour are of relevance for metastatic potential and control by antimetastatic drugs, and suggest that for DTIC such antimetastatic action may participate to its clinical antitumour effects.
Similar content being viewed by others
References
Fidler, I. J., 1984, Recent concepts of cancer metastasis and their implications for therapy. Cancer Treatment Reports, 68, 193–198.
[2]Giraldi, T., Sava, G., Cuman, R., Nisi, C., and Lassiani, L., 1981, Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt, (±)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma. Cancer Research, 41, 2524–2528.
Giraldi, T., Sava, G., Cherubino, R., Bottiroli, G., and Mazzini, G., 1984, Effects of DTIC, DM-COOK and ICFR-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry. Clinical and Experimental Metastasis, 2, 151–159.
James, S. E., and Salsbury, A. J., 1974, Effect of (±)-1,2-bis(3,5-dioxopiperazin-l-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma. Cancer Research, 34, 839–842.
Sacchi, A., Corsi, A., Caputo, M., and Zupi, G., 1979, In vitro and in vivo selection of two Lewis lung carcinoma cell lines. Tumori, 65, 657–664.
Salsbury, A. J., Burrage, K., and Hellmann, K., 1970, Inhibition of metastatic spread by ICRF 159: selective deletion of malignant characteristics. British Medical Journal, 4, 344–346.
Salsbury, A. J., Burrage, K., and Hellmann, K., 1974, Histological analysis of the antimetastatic effects of (±)-1,2-bis(3,5-dioxopiperazin-1-yl)propane. Cancer Research, 34, 843–849.
Sato, T., Takusagawa, K., Asoo, N., Ariji, F., Shida, K., Kumano, N., and Konno, K., 1982, Ultrastructure of the Lewis lung carcinoma. European Journal of Cancer and Clinical Oncology, 18, 369–376.
Sava, G., Giraldi, T., Zupi, G., and Sacchi, A., 1984, Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential. Invasion and Metastasis, 4, 171–178.
Starace, G., Badaracco, G., Greco, G., Sacchi, A., and Zupi, G., 1982, DNA content distribution of in vivo and in vitro lines of Lewis lung carcinoma. European Journal of Cancer and Clinical Oncology, 18, 973–978.
Zamboni, L., and De Martino, C., 1967, Buffered picric acid-formaldehyde: a new rapid fixative for electron microscopy. Journal of Cell Biology, 35, 148A.
Zupi, G., Mauro, F., and Sacchi, A., 1980, Cloning in vitro and in vivo of Lewis lung carcinoma, properties and characteristics. British Journal of Cancer, 41, Suppl. 4, 309–310.
Zupi, G., Cavallari, A., Greco, C., and Sacchi, A., 1984, Lewis lung carcinoma lines with different metastatic behaviour: response to ICRF-159. Anticancer Research, 4, 91–95.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grill, V., Mallardi, F., Zorzet, S. et al. Morphological analysis of metastatic potential and antimetastatic drug effects in mice bearing two lines of Lewis lung carcinoma. Clin Exp Metast 5, 233–244 (1987). https://doi.org/10.1007/BF00124305
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00124305